Foresite Capital is a leading venture capital and growth equity firm focused on healthcare and life sciences. The firm invests in startups at all stages, from seed to late-stage rounds, with a particular emphasis on Series A to C investments. Foresite Capital has raised multiple funds, including a recent $900 million fund, to support innovative companies in biotech, genomics, and digital health.
The firm's portfolio includes notable companies such as 10x Genomics, 23andMe, Insitro, and Relay Therapeutics. Foresite Capital offers strategic guidance and operational support to its portfolio companies, leveraging its team's deep expertise in healthcare and life sciences. The firm is known for making significant investments in cutting-edge technologies, including AI-driven drug discovery and development platforms.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
